The Technical Analyst
Select Language :
Deciphera Pharmaceuticals [DCPH]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Deciphera Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Deciphera Pharmaceuticals is listed at the  Exchange

3.62% $15.73

America/New_York / 28 mar 2024 @ 16:00


Deciphera Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 270.99 mill
EPS: -2.29
P/E: -6.87
Earnings Date: Apr 30, 2024
SharesOutstanding: 80.80 mill
Avg Daily Volume: 0.533 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -6.87 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.14x
Company: PE -6.87 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 15.08 - 16.38

( +/- 4.14%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-15 Sherman Matthew L Buy 17 275 Common Stock
2024-02-16 Sherman Matthew L Sell 2 615 Common Stock
2024-02-15 Sherman Matthew L Buy 69 100 Stock Option (Right to Buy)
2024-02-15 Kelly Thomas Patrick Buy 17 275 Common Stock
2024-02-16 Kelly Thomas Patrick Sell 3 010 Common Stock
INSIDER POWER
31.86
Last 99 transactions
Buy: 6 983 334 | Sell: 3 513 431

Forecast: 16:00 - $15.73

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $15.73
Forecast 2: 16:00 - $15.73
Forecast 3: 16:00 - $15.73
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $15.73 (3.62% )
Volume 0.764 mill
Avg. Vol. 0.533 mill
% of Avg. Vol 143.39 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Deciphera Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Deciphera Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Deciphera Pharmaceuticals Inc

Last 10 Buy & Sell Signals For DCPH

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$14.14N/AActive
Profile picture for
            Deciphera Pharmaceuticals Inc

DCPH

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Last 10 Buy Signals

Date Signal @
YAKUSDMar 28 - 17:13842.58
WNEARUSDMar 28 - 17:137.20
OHMUSDMar 28 - 17:1412.31
NTRNUSDMar 28 - 17:041.211
YMUSDMar 28 - 16:5940 139
AIOZUSDMar 28 - 17:060.906
WEGLDUSDMar 28 - 17:0460.82
JOEUSDMar 28 - 17:030.903
ETHUPUSDMar 28 - 17:0434.60
RLCUSDMar 28 - 17:02$4.01

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.